Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry, is introducing its new generation of ambr ® 15 cell culture automated microbioreactor system.

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr 250 high throughput (ht) perfusion, a new automated parallel ...

Sartorius Stedim Biotech (SSB) signed a cooperation agreement with Lonza covering cell culture media. SSB will assume global sales and marketing of Lonza’s media and buffers used in the ...

Sartorius Stedim Biotech partners with cell culture media specialist SAFC Biosciences® to provide world-class fluid management and liquid/powder system solutions Global agreement strengthens ...

Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, today announced a substantial expansion of its product array in the cell culture range. The company signed ...

Sartorius Stedim Biotech (SSB) (Paris:DIM), a leading international supplier of the biopharmaceutical industry, and Lonza announced today that they ha ...

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, announced the completion of a multi-year ...

AUBAGNE, France, July 29, 2021/ PRNewswire/-- The life science company Sartorius Stedim Biotech acquired cell culture specialist Xell AG headquartered in Bielefeld, Germany. "I would like to ...

New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture Sartorius Stedim Biotech (SSB) introduced ...

Sartorius Stedim Biotech S.A. 2024 Q2 - Results - Earnings Call Presentation Fri, Jul. 19, 2024 Sartorius Stedim Biotech S.A. GAAP EPS of €1.08, revenue of €1.37B ...

Sartorius Stedim Biotech 9M GAAP EPS of €6.58, revenue of €2.6B; updates FY22 guidance SA News Wed, Oct. 19, 2022 Sartorius Stedim Biotech S.A. GAAP EPS of €4.40, revenue of €1.72B ...